1. Sweden Stocks

  2. •

    Technology

  3. •

    Hardware, Equipment & Parts
Gasporox AB (publ)

Gasporox AB (publ)

GPX.ST
Gasporox AB (publ)SE flagStockholm Stock Exchange
7.10
SEK
+0.15
- -
66.41MMarket Cap
Gasporox AB (publ)
GPX.ST
(Stockholm Stock Exchange)

Recent

price

7.10

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
0.26
0.65
1.1
1.15
1.65
1.62
1.83
2.49
3.65
3.88
- -
2.91
Revenue per Share
- -
-0.75
-1.09
-1.12
-1.16
-0.9
-0.57
-0.63
-0.51
-0.14
-0.3
- -
-1.2
Basic EPS, GAAP
- -
-1.62
-1.57
-1.23
-1.97
-0.99
-0.79
-1.15
-0.96
-0.46
-0.4
- -
-0.27
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
-3.25
0.66
0.5
0.57
-6.26
-6.76
-7.09
-7.98
-8.45
-8.82
- -
- -
Book Value per Share
- -
-0.15
3.54
1.52
3.04
3.49
3.09
1.74
0.88
0.45
0.56
- -
-0.44
Tangible Book Value per Share
- -
5
3
5
5
6
8
9
9
9
9
- -
9
Basic Weighted Avg Shares
- -
1
2
5
6
10
12
16
21
31
34
32
27
Sales/Revenue/Turnover
- -
-278.52
-168.77
-107.02
-105.39
-54.77
-35.02
-34.25
-23.18
-4.2
-8.59
-21.64
-37.45
Operating Margin (%)
- -
1
1
2
2
2
3
3
3
4
5
6
6
Depreciation Expense
- -
-4
-4
-5
-6
-6
-4
-5
-4
-1
-3
-8
-11
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
-289.05
-168.14
-102.05
-100.57
-54.82
-35.03
-34.25
-20.48
-3.96
-7.85
-24.42
-41.24
Profit Margin (%)
-4
-1
12
7
17
15
24
15
16
5
6
11
9
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
2
15
- -
LT Debt
- -
4
17
14
27
30
34
29
24
23
27
20
19
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
-224.58
-234.02
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
1
- -
- -
LT Borrowings
2
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
9
9
Market Capitalization
76
69
68

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
17
29
27
Cash, Cash Equivalents & STI
7
18
12
Accounts Receivable, Net
3
- -
- -
Inventories
6
7
7
Total Current Liabilities
11
15
18
Payables & Accruals
- -
- -
- -
ST Debt
1
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
33.85%
-9.24%
-25.58%
Free Cash Flow
26.12%
47.69%
255.77%
Net Income, GAAP
26.96%
47.27%
188.15%
Sales/Revenue/Turnover
42.89%
22.06%
-7.42%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
9
10
8
8
34
2025
4
7
11
- -
32
2026
9
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
-0.01
-0.17
-0.12
-0.3
2025
-0.49
-0.41
0.11
- -
- -
2026
-0.17
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Shenzhen Yitoa Intelligent Control Co.,Ltd. (300131.SZ)
Yes Optoelectronics (Group) Co., Ltd. (002952.SZ)
Transtouch Technology Inc. (3623.TWO)
Syrma SGS Technology Limited (SYRMA.NS)
Suzhou Jinfu Technology Co., Ltd. (300128.SZ)
Jiangsu Boxin Investing&Holdings Co.,Ltd. (600083.SS)
Business
Gasporox AB (publ) (GPX.ST) develops and commercializes tunable diode laser absorption spectroscopy (TDLAS) technology, specializing in Gas in Scattering Media Absorption Spectroscopy (GASMAS) for non-destructive, non-intrusive headspace gas analysis and leak detection in pharmaceutical, food, and beverage packaging; the company offers benchtop instruments including the GPX1500 Vial for oxygen inspection in vials and ampoules, GPX1500 Film Pharma for intravenous bags and pouches, and GPX1500 Film Food for flexible food packaging; sensor modules such as VialArch for in-line integration on production lines, GasSpect series (O2, H2O, CO2, CO2 & Bar, Flex) for various headspace gases, CellSpect CO2 for leak testing, GPX Porosity for pharmaceutical substrates, and AutoMAP for modified atmosphere packaging; it also provides customized measurement services, calibration, training, IQ/OQ protocols, and integration support. Founded in 2005 and headquartered in Lund, Sweden, Gasporox operates globally with approximately 20 employees, targeting quality control, manufacturing, and R&D in pharma, food, and beverage sectors. Recent developments include the launch of BottleArch in early 2025 for non-intrusive testing of large-volume parenterals at up to 600 units per minute, a SEK 15.4 million strategic investment from Gobia Enterprises in January 2025 to fund pharmaceutical market expansion and technology development, a SEK 4.4 million order for VialArch from Maxcann in December 2025, and the upcoming debut of the plug-and-play LineArch in-line CCIT/HSA system at CPHI 2025 in Frankfurt.